当前位置:BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 79500BCMA CHO Recombinant Cell Line (High or Low Expression)
Anti-BCMA CAR /NFAT (Luciferase) Re
Anti-CD19 CAR / NFAT (Luciferase) R
Recombinant clonal stable CHO cell line constitutively expressing full length human BCMA protein, also known as TNFRSF17, (Genbank #NM_001192). Surface expression of BCMA was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of BCMA expression, (High. Medium, Low), to mimic different stages of cancer target cells with various BCMA expression levels.
This product has been cited 3 times.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
请输入账号
请输入密码
请输验证码
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,化工仪器网对此不承担任何保证责任。
温馨提示:为规避购买风险,建议您在购买产品前务必确认供应商资质及产品质量。